TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Kårhuset Pharmen AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
461
|
1,086
|
825 |
| Financial expenses |
28
|
66
|
197 |
| Earnings before taxes |
4,936
|
-74
|
-375 |
| EBITDA |
4,637
|
256
|
213 |
| Total assets |
7,885
|
10,912
|
10,235 |
| Current assets |
7,885
|
1,125
|
838 |
| Current liabilities |
1,462
|
266
|
225 |
| Equity capital |
6,423
|
9,349
|
8,799 |
| - share capital |
26
|
25
|
5,675 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.5%
|
85.7%
|
86.0% |
| Turnover per employee |
461
|
1,086
|
825 |
| Profit as a percentage of turnover |
1070.7%
|
-6.8%
|
-45.5% |
| Return on assets (ROA) |
63.0%
|
-0.1%
|
-1.7% |
| Current ratio |
539.3%
|
422.9%
|
372.4% |
| Return on equity (ROE) |
76.8%
|
-0.8%
|
-4.3% |
| Change turnover |
-645
|
203
|
-71 |
| Change turnover % |
-58%
|
23%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.